Publicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (31)

2022

  1. CD6 deficiency impairs early immune response to bacterial sepsis

    iScience, Vol. 25, Núm. 10

  2. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution

    Prostate, Vol. 82, Núm. 14, pp. 1331-1337

2020

  1. CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer

    Translational Lung Cancer Research, Vol. 9, Núm. 4, pp. 1074-1083

  2. Multifaceted effects of soluble human CD6 in experimental cancer models

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

  3. Production and use of adeno-associated virus vectors as tools for cancer immunotherapy

    Methods in Enzymology (Academic Press Inc.), pp. 185-203

  4. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents

    Cells, Vol. 9, Núm. 12

  5. Transforming growth factor beta (TGF-β) activity in immuno-oncology studies

    Methods in Enzymology (Academic Press Inc.), pp. 129-172

2019

  1. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity

    Cell Metabolism, Vol. 30, Núm. 4, pp. 754-767.e9

  2. Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies

    Current Protocols in Pharmacology, Vol. 86, Núm. 1

  3. Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a

    Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704

2018

  1. Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis

    Cellular and Molecular Immunology, Vol. 15, Núm. 10, pp. 898-906

  2. Gut microbiota metabolites for sweetening type i diabetes

    Cellular and Molecular Immunology, Vol. 15, Núm. 2, pp. 92-95

  3. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

    OncoImmunology, Vol. 7, Núm. 6

2017

  1. Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis"

    Antimicrobial agents and chemotherapy

  2. Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1

    European Journal of Immunology, Vol. 47, Núm. 7, pp. 1108-1118

  3. Immunomodulatory effects of soluble CD5 on experimental tumor models

    Oncotarget, Vol. 8, Núm. 64, pp. 108156-108169

  4. Protective effects of human and mouse soluble scavenger-like CD6 lymphocyte receptor in a lethal model of polymicrobial sepsis

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 1

  5. Relevance of CD6-mediated interactions in the regulation of peripheral T-cell responses and tolerance

    Frontiers in Immunology, Vol. 8, Núm. MAY

  6. Trial watch: Immune checkpoint blockers for cancer therapy

    OncoImmunology, Vol. 6, Núm. 11

2016

  1. CD6 modulates thymocyte selection and peripheral T cell homeostasis

    Journal of Experimental Medicine, Vol. 213, Núm. 8, pp. 1387-1397